4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-026937
EVP, COO, Head of Commercial sold 552 shares at $18.18 ($10,036)
- EVP, COO, Head of Commercial acquired 1,567 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2022-04-29 | Option exercise | +1,567 | 3,989 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2022-05-02 | Sale | −552 | $18.18 | $10,036 | 3,437 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2022-04-29 | Option exercise · Restricted Stock Units | −1,567 | 1,567 | D | ||
| Open-market sales · 552 sh · avg $18.18 · $10,036 | |||||||
Loading xslF345X03/doc4.xml…